Sensyne Health plc announced earnings results for the full year ended April 30, 2021. For the full year, the company announced sales was GBP 9.095 million compared to GBP 2.050 million a year ago. Operating loss was GBP 27.853 million compared to GBP 22.449 million a year ago. Net loss was GBP 27.521 million compared to GBP 21.839 million a year ago. Basic loss per share from continuing operations was GBP 0.2 compared to GBP 0.17 a year ago.